InvestorsHub Logo
Followers 53
Posts 4314
Boards Moderated 0
Alias Born 02/28/2010

Re: None

Wednesday, 12/19/2012 9:09:33 AM

Wednesday, December 19, 2012 9:09:33 AM

Post# of 130513
.20-.25 on 12/31/2012 seems realistic.

I expect the MANF comparative study data before then.

This is the most undervalued bio-tech in the market.

Fair value is .17 based on current information.